IFP Advisors
CRDF icon

IFP Advisors’s Cardiff Oncology CRDF Stock Holding History

IFP Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.67K Buy
3,859
+19
+0.5% +$20 ﹤0.01% 3858
2026
Q2 		$4.99K Buy
3,840
+3,835
+76,700% +$6.09K ﹤0.01% 3793
2026
Q1 		$8 Buy
+5
New +$10 ﹤0.01% 4977
2025
Q2 		– Hold
0
– – – 4730
2019
Q1 		– Sell
-7
Closed – – 2548
2018
Q4 		$0 Sell
7
-28
-80% -$128 ﹤0.01% 3577
2018
Q3 		$0 Hold
35
– – ﹤0.01% 3855
2018
Q2 		$0 Hold
35
– – ﹤0.01% 3901
2018
Q1 		$1K Hold
35
– – ﹤0.01% 3612
2017
Q4 		$1K Sell
35
-7
-17% -$310 ﹤0.01% 3663
2017
Q3 		$2K Hold
42
– – ﹤0.01% 3728
2017
Q2 		$4K Hold
42
– – ﹤0.01% 3488
2017
Q1 		$3K Sell
42
-41
-49% -$5.57K ﹤0.01% 3500
2016
Q4 		$13K Sell
83
-105
-56% -$24.5K ﹤0.01% 2738
2016
Q3 		$61K Buy
188
+32
+21% +$11.7K ﹤0.01% 1685
2016
Q2 		$51K Buy
+156
New +$53.7K ﹤0.01% 1748
2016
Q1 		– Sell
-7
Closed -$3K – 2554
2015
Q4 		$3K Buy
+7
New +$2.74K ﹤0.01% 3164

Other funds holding CRDF

GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $146M AUM 18.19% 1-Year Est. Return
Baker Ellis Asset Management
Baker Ellis Asset Management Vancouver, Washington $917M AUM 26.82% 1-Year Est. Return
Capital Advisors Wealth Management
Capital Advisors Wealth Management Yakima, Washington $888M AUM 16.06% 1-Year Est. Return
LWA
Ledgewood Wealth Advisors Exeter, New Hampshire $181M AUM 9.93% 1-Year Est. Return
TCOT
Trust Company of Toledo Holland, Ohio $1.25B AUM 28.18% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

IFP Advisors's CRDF Position: Q3 2026 in Review

IFP Advisors increased its Cardiff Oncology (CRDF) stake by 0.49% in Q3 2026, buying an estimated $20 and bringing the position to 3,859 shares worth $4.67K. The position accounts for ﹤0.01% of the portfolio, ranked #3858.

IFP Advisors first reported a position in CRDF in Q4 2015 and has held it in 15 quarters since. The position peaked at $61K in Q3 2016. 11 funds tracked by Wall St. Rank hold CRDF as of Q3 2026.

  • IFP Advisors held 3,859 shares of Cardiff Oncology worth $4.67K as of Q3 2026.
  • IFP Advisors bought 19 Cardiff Oncology shares in Q3 2026, an estimated $20.
  • Cardiff Oncology made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #3858 holding.
  • IFP Advisors first reported a position in Cardiff Oncology in Q4 2015 and has held it in 15 quarters since.
  • IFP Advisors's Cardiff Oncology position peaked at $61K in Q3 2016.
  • 11 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.